PGNY Progyny

Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced the acquisition of BenefitBump, a comprehensive parental leave benefits navigation program for new and growing families. This addition enhances Progyny’s fertility and family building offering, extending the company's ability to further serve the needs of families on their journey from pregnancy to early childhood and beyond.

With of parents seeking greater support to manage responsibilities at work and home, Progyny’s enhanced suite of solutions aims to reduce member stress, improve recruitment, return-to-work and retention rates, and foster proactive child and family health. By addressing gaps across the spectrum, from fertility to postpartum support and parental leave navigation, the company helps eliminate fragmentation and enhances multi-dimensional outcomes for families.

"The acquisition of BenefitBump extends our ability to provide compassionate and dedicated support to give members more confidence along their parenting journey," said Pete Anevski, Chief Executive Officer, Progyny. "BenefitBump’s high-touch, guided support integrates seamlessly into our existing patient care model and aligns with our commitment to improving member well-being through a higher standard of care."

Alongside the offerings Progyny is known for across preconception, fertility, pregnancy, postpartum, and menopause, the enhanced suite of services will include:

  • Clinical social worker-led parental wellness program
  • Comprehensive parental leave and benefits navigation
  • Care and resource navigation for child behavior concerns and neurodiverse care
  • Clinician-facilitated peer support groups

“Navigating employee benefits and leave programs is complex and adds unnecessary stress for families. Every new parent will experience leave, yet it has been an underserved area. BenefitBump was built by listening to the challenges and needs of parents, with the goal of easing their anxiety and ensuring employers and employees get the most value from family support investments,” said Scott Liebman, Founder, BenefitBump. “We’re thrilled to join Progyny, an innovator and leader in the family building space, and together provide the holistic support that families deserve.”

For more information about Progyny visit

About Progyny

Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians. 

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.  

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit . 

For Further Information, Please Contact:

Investors:

James Hart

Media:

Alexis Ford



EN
28/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny Appoints Two Renowned Women’s Health Experts to Medical Adviso...

Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board Medical Advisory Board additions support company’s growing product offerings across women’s health and family building NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fell...

 PRESS RELEASE

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conferenc...

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny’s ...

 PRESS RELEASE

Progyny, Inc. Announces First Quarter 2025 Results

Progyny, Inc. Announces First Quarter 2025 Results Reports Record Revenue of $324.0 Million, Reflecting 16.5% GrowthRaises Full Year Guidance Due to Strong Start to the YearEarly Selling Season Activity Reflects Ongoing Demand in Women's Health and Family Building Solutions NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced its financial results for the three-month period ended March 31, 2025 (“the first quarter of 2025”) as compared to the three-month perio...

 PRESS RELEASE

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Rep...

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, May 8, 2025. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference ...

 PRESS RELEASE

Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating ...

Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer The leadership additions support the company’s continued ability to scale as it delivers the right care model for women’s health and family building NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women’s health and family building, today announced the appointments of Melissa Cummings as the company’s first Chief Operating Officer (COO) and Geoffrey Clapp as its first Chief Product Officer (CPO). The additions to the executive ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch